Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Trading Statement

5 May 2017 07:00

RNS Number : 2218E
Redcentric PLC
05 May 2017
 

 

05 May 2017

 

Redcentric plc

("Redcentric" or the "Company")

 

Trading Update

 

Redcentric plc (AIM: RCN), a leading UK IT managed services provider, is today issuing a trading update for the year ended 31 March 2017.

 

The Company's trading results for the year were in line with the Board's expectations. Redcentric experienced good sales momentum in the year with a number of key contract wins and renewals in both the public and private sectors.

 

Net debt as at 31 March 2017 was £39.5m, an improvement over the previously reported average net debt position to 30 November 2016 of £42.0m. This improvement was despite the significant exceptional items related to the forensic review.

 

Our lending banks have remained supportive over recent months and the Company is pleased to announce that amended debt facilities are now in place. Waivers in relation to historic covenant breaches have been secured such that the Company is fully compliant with its facilities. 

 

Good progress has been made with regard to the remedial programme outlined at the interim results in December. The finance team has been further strengthened and a number of improvements made to internal systems and controls.

 

Further details on the above will be included within the Company's full year results for the year ended 31 March 2017 to be announced on 29 June 2017.

 

Fraser Fisher, Chief Executive Officer, said;

 

"We are pleased to be able to report that trading is in line with expectations. Throughout the challenges at the end of last year, we have continued to enjoy the support of our stakeholders including customers, banks and loyal colleagues. A great deal of work has been carried out in the past few months to execute the remedial plan, strengthening our reporting and control systems."

 

 

Enquiries:

 

Redcentric plc

Via Tulchan Communications

Fraser Fisher, Chief Executive

Peter Brotherton, Chief Financial Officer

 

 

Numis Securities - NOMAD & Joint Broker

+44 (0) 20 7260 1000

Simon Willis / Oliver Hardy / Ben Stoop

 

 

finnCap Ltd - Joint Broker 

+44 (0) 20 7220 0500

Stuart Andrews / Rhys Williams

 

 

Tulchan Communications

+44 (0) 207 353 4200

James Macey White / Matt Low

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSSURBWAVRAR
Date   Source Headline
31st May 202411:46 amRNSForm 8.5 (EPT/NON-RI)
31st May 20249:23 amPRNForm 8.3 - Redcentric Plc
30th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
30th May 202410:34 amRNSForm 8.5 (EPT/NON-RI)
30th May 20249:49 amPRNForm 8.3 - Redcentric Plc
29th May 20243:13 pmRNSForm 8.3 - Redcentric PLC
29th May 202411:43 amRNSForm 8.5 (EPT/NON-RI)
29th May 20249:30 amPRNForm 8.3 - Redcentric Plc
29th May 20247:00 amRNSForm 8.3 - Redcentric plc
28th May 20245:17 pmRNSForm 8.3 - Redcentric plc
28th May 20243:57 pmRNSForm 8.3 - Redcentric plc
28th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
28th May 20242:28 pmRNSSI Redstone LLP - Form 8.3 - Redcentric plc
28th May 20241:35 pmEQSForm 8.3 - Apex Fundrock Limited : Re Redcentric plc
28th May 20241:16 pmRNSForm 8.5 (EPT/NON-RI) - Amendment
28th May 202411:49 amRNSForm 8.3 - Redcentric plc
28th May 202411:06 amRNSForm 8.3 - Redcentric PLC
28th May 202410:24 amRNSForm 8.5 (EPT/NON-RI)
28th May 20249:56 amPRNCorrection: Statement regarding Redcentric plc ("Redcentric")
28th May 20249:13 amPRNStatement regarding Redcentric plc ("Redcentric")
24th May 20244:19 pmRNSResponse to press speculation
16th May 20247:00 amRNSTrading Update
14th May 20241:00 pmRNSExercise of Options
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.